Geology ReportsSearch

Geology topics

Kathleen Esposito

Publications and source records attributed to Kathleen Esposito.

5 recordsLinked to original sources

A multi-disciplinary approach to the removal of emerging contaminants in municipal wastewater treatment plans in New York State, 2003-2004

Across the United States, there is a rapidly growing awareness of the occurrence and the toxicological impacts of natural and synthetic trace compounds in the environment. These trace compounds, referred to as emerging contaminants (ECs), are reported to cause a range of negative impacts in the environment, such as adverse effects on biota in receiving streams and interference with the normal functions of the endocrine system, which controls growth and development in living organisms. Wastewater treatment plants (WWTPs) have been identified as a key collection point for ECs in the water cycle and potentially an ideal location at which to treat to remove them, thereby mitigating their release into the environment ( Figure 1 ). This presents wastewater industry professionals with both a significant opportunity and a tremendous challenge: to identify cost effective treatment processes that can remove or reduce these contaminants before they are released into the environment. Although WWTPs have been identified as strategic focal points and potential treatment locations for the removal of ECs from the environment, little is known about the nature, variability, transport and fate of this class of compounds in typical wastewaters and treatment facilities in the United States. Furthermore few studies have been performed to monitor or understand the capability of conventional or innovative wastewater treatment processes to remove or reduce the concentrations of a wide variety of ECs at wastewater facilities. This study was designed to provide baseline information on this topic. While other studies have examined the occurrence of a limited number of representative contaminants in the environment (generally five to 10 compounds), this study is unique in that it provides information on a comprehensive list of ECs (63 ECs in total, Contaminant List in Appendix A, not included here) in the wastewater collection and treatment systems for four diverse communities over a two-year period. (It should be noted that the study is ongoing and additional data are pending but only 18 months of data are presented in this paper). The study was conducted in two phases. Phase 1 was designed to provide information concerning the general character and concentration of ECs commonly detected in wastewaters, the variability over a prolonged period of time, the transport and fate of ECs through typical wastewater treatment plants operating with a range of conventional technologies and the impact of WWTP discharges on receiving streams. It also provided guidance in understanding the capability of distinct wastewater treatment processes or technologies to reduce or remove ECs. The second phase of the study focused on one of the most common wastewater treatment processes operated in the United States, the Activated Sludge process. Using four controlled parallel activated sludge pilots, a more detailed assessment of the impact of Sludge Retention Time (SRT) on the reduction or removal of ECs was performed.

New York

Pharmaceuticals, hormones, anthropogenic waste indicators, and total estrogenicity in liquid and solid samples from municipal sludge stabilization and dewatering

The ubiquitous presence of pharmaceuticals and other emerging contaminants, or trace organic compounds, in surface water has resulted in research and monitoring efforts to identify contaminant sources to surface waters and to better understand loadings from these sources. Wastewater treatment plant discharges have been identified as an important point source of trace organic compounds to surface water and understanding the transport and transformation of these contaminants through wastewater treatment process is essential to controlling their introduction to receiving waters.

Open-File Report

Pharmaceutical formulation facilities as sources of opioids and other pharmaceuticals to wastewater treatment plant effluents

Facilities involved in the manufacture of pharmaceutical products are an under-investigated source of pharmaceuticals to the environment. Between 2004 and 2009, 35 to 38 effluent samples were collected from each of three wastewater treatment plants (WWTPs) in New York and analyzed for seven pharmaceuticals including opioids and muscle relaxants. Two WWTPs (NY2 and NY3) receive substantial flows (>20% of plant flow) from pharmaceutical formulation facilities (PFF) and one (NY1) receives no PFF flow. Samples of effluents from 23 WWTPs across the United States were analyzed once for these pharmaceuticals as part of a national survey. Maximum pharmaceutical effluent concentrations for the national survey and NY1 effluent samples were generally <1 microg/L. Four pharmaceuticals (methadone, oxycodone, butalbital, and metaxalone) in samples of NY3 effluent had median concentrations ranging from 3.4 to >400 microg/L. Maximum concentrations of oxycodone (1700 microg/L) and metaxalone (3800 microg/L) in samples from NY3 effluent exceeded 1000 microg/L. Three pharmaceuticals (butalbital, carisoprodol, and oxycodone) in samples of NY2 effluent had median concentrations ranging from 2 to 11 microg/L. These findings suggest that current manufacturing practices at these PFFs can result in pharmaceuticals concentrations from 10 to 1000 times higher than those typically found in WWTP effluents.

Environmental Science & Technology

Evaluating the behavior of gadolinium and other rare earth elements through large metropolitan sewage treatment plants

A primary pathway for emerging contaminants (pharmaceuticals, personal care products, steroids, and hormones) to enter aquatic ecosystems is effluent from sewage treatment plants (STP), and identifying technologies to minimize the amount of these contaminants released is important. Quantifying the flux of these contaminants through STPs is difficult. This study evaluates the behavior of gadolinium, a rare earth element (REE) utilized as a contrasting agent in magnetic resonance imaging (MRI), through four full-scale metropolitan STPs that utilize several biosolids thickening, conditioning, stabilization, and dewatering processing technologies. The organically complexed Gd from MRIs has been shown to be stable in aquatic systems and has the potential to be utilized as a conservative tracer in STP operations to compare to an emerging contaminant of interest. Influent and effluent waters display large enrichments in Gd compared to other REEs. In contrast, most sludge samples from the STPs do not display Gd enrichments, including primary sludges and end-product sludges. The excess Gd appears to remain in the liquid phase throughout the STP operations, but detailed quantification of the input Gd load and residence times of various STP operations is needed to utilize Gd as a conservative tracer.

Environmental Science & Technology

A multi-disciplinary approach to the removal of emerging contaminants in municipal wastewater treatment plants in New York state (2003-2004)

Across the United States, there is a rapidly growing awareness of the occurrence and the toxicological impacts of natural and synthetic trace compounds in the environment. These trace compounds, referred to as emerging contaminants (ECs), are reported to cause a range of negative impacts in the environment, such as adverse effects on biota in receiving streams and interference with the normal functions of the endocrine system, which controls growth and development in living organisms.

New York